Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.UK's Aviva takes full ownership of India unit after New Delhi eases foreign investment rules
Aviva detects record £230m in bogus insurance claims as use of AI rises
Berenberg initiates on Aviva with 'buy' rating, sees 36% total return
Aviva's pension profits are under pressure, but RBC still sees upside
Legal & General and Standard Life investors loved Aviva's mixed results
Aviva premiums jump 19% but bulk annuity sales fall
Aviva Posts Rise in Insurance Premiums
Aviva: Strong Results And Capital Returns Support Continued Upside
Could Aviva hand investors a 30% return in the next 12 months? This bank thinks so
Aviva shares: why three banks think the FTSE 100 insurer is still too cheap
Aviva plc (AVVIY) Q4 2025 Earnings Call Transcript
Aviva hikes dividend 10% and unveils £350m buyback as 2026 targets delivered early
Aviva: Strategy May Continue To Deliver Strong Results (Rating Downgrade)
Aviva set to resume buybacks as full-year results approach
Bloomberg's 2026 Watch List Flags 5 Ideal 'Safer' February Dividend Buys
Aviva exposed as motor insurers face new AI de-rating, Barclays warns
Aviva presents "attractive' entry point for investors - broker
Aviva is transformed and is a 'buy' says broker
Aviva preferred over L&G as broker reviews life insurers
Aviva Bio Announces FDA Guidance on Development Pathway for Women's Testosterone Therapy and New Evidence of a Reduced Risk of Breast Cancer Cell Proliferation for AVA-291